Navitus Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 4.00 Cr
as on 12-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 12-12-2024
- Revenue %
(FY 2023)
- Profit -8182.18%
(FY 2023)
- Ebitda -8300.49%
(FY 2023)
- Net Worth 2226.41%
(FY 2023)
- Total Assets 257.24%
(FY 2023)
About Navitus Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Nilesh Nemade, Shailesh Dhabekar, Sameer Bhalerao, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290MH2019PTC319422
- Company No.
319422
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2019
- Date of AGM
10 Jan 2024
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Navitus Chemicals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Nemade  | Director | 01-Jul-2020 | Current |
| Shailesh Dhabekar | Director | 05-Feb-2022 | Current |
| Sameer Bhalerao | Director | 11-Jan-2019 | Current |
| Shyam Titirmare | Director | 11-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Navitus Chemicals.
Navitus Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 8182.18% decrease in profit. The company's net worth Soared by an impressive increase of 2226.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Navitus Chemicals?
Unlock access to Navitus Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- White&Trust Pharmaceuticals (India) Private LimitedActive 12 years 5 months
Shailesh Dhabekar and Sameer Bhalerao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Feb 2023 | ₹5.00 Cr | Open |
How Many Employees Work at Navitus Chemicals?
Unlock and access historical data on people associated with Navitus Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Navitus Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Navitus Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
